Tesofensine

Tesofensine

Tesofensine has randomized human trials showing weight loss, having started as a candidate for neurodegenerative disease. It is a triple monoamine...

About:

A triple monoamine reuptake inhibitor, not a peptide, tested in phase II obesity trials with reported weight loss.

MetabolicCapsules or research liquid

What does this peptide do?

Backed by human trial data, narrower than the strongest evidence. Research focuses on obesity and weight loss.

Obesity research

Tested in phase II obesity trials.

Weight loss

Those trials reported weight loss as an outcome.

Evidence grade

B

Highest evidence grade among the graded claims: B. Grades reflect study strength, not benefit.

What are the benefits and side effects of this peptide

What research says it may help with

Tesofensine has randomized human trials showing weight loss, having started as a candidate for neurodegenerative disease.

Who should avoid it

People who are pregnant or breastfeeding
Children and adolescents
People taking antidepressants or stimulants, given the monoamine mechanism
Known hypersensitivity to the compound
Uncontrolled high blood pressure

See the safety section. Absence of a flag is not evidence of safety.

A grade reflects evidence strength, not a recommendation to use this compound; a strong grade can attach to a harmful effect.

How to store this peptide

Lyophilized storage

Store at room temperature, below 25 °C, in a dry place.

Storage Handling

Keep the container tightly closed and away from moisture.

Related research

Related research is coming soon for this peptide.

Related peptides